Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

SHE:002864 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	973.86	978.2	971.04	883.76	667.66
Other Revenue	-	2.63	3.26	3.73	2.66
Revenue	973.86	980.83	974.29	887.48	670.31
Revenue Growth (YoY)	-0.71%	0.67%	9.78%	32.40%	9.77%
Cost of Revenue	381.52	413.74	408.25	370.36	255.52
Gross Profit	592.35	567.09	566.04	517.12	414.79
Selling, General & Admin	436.86	418.79	416.11	386.15	305.6
Research & Development	37.54	20.26	18.23	14.03	12.97
Other Operating Expenses	1.08	10.61	10.23	9.29	7.15
Operating Expenses	475.47	453.98	452.94	414.07	329.39
Operating Income	116.87	113.11	113.1	103.05	85.39
Interest Expense	-	-6.11	-13.92	-3.49	-2.85
Interest & Investment Income	0.63	22.06	17.18	11.78	8.32
Other Non Operating Income (Expenses)	19.69	0.31	2.55	-5.27	1.19
EBT Excluding Unusual Items	137.19	129.37	118.91	106.06	92.06
Gain (Loss) on Sale of Investments	-	-1.56	-0.11	-	-
Gain (Loss) on Sale of Assets	-0.01	0.17	-	-	0.15
Asset Writedown	-0.23	-0.81	-0.08	-0	-0.19
Other Unusual Items	-	2.08	0.46	2.97	2.49
Pretax Income	136.95	129.25	119.18	109.03	94.5
Income Tax Expense	17.03	17.7	16.03	14.47	13.4
Earnings From Continuing Operations	119.92	111.55	103.15	94.56	81.09
Minority Interest in Earnings	0.35	-1.11	-1.98	-1.39	-1.98
Net Income	120.27	110.43	101.16	93.17	79.12
Net Income to Common	120.27	110.43	101.16	93.17	79.12
Net Income Growth	8.91%	9.16%	8.58%	17.77%	10.22%
Shares Outstanding (Basic)	105	96	86	85	86
Shares Outstanding (Diluted)	105	98	86	85	86
Shares Change (YoY)	7.02%	13.03%	1.16%	-0.60%	-0.56%
EPS (Basic)	1.15	1.15	1.18	1.09	0.92
EPS (Diluted)	1.15	1.13	1.17	1.09	0.92
EPS Growth	1.77%	-3.42%	7.34%	18.48%	10.84%
Free Cash Flow	74.54	41.53	69.53	35.36	21.06
Free Cash Flow Per Share	0.71	0.42	0.80	0.41	0.24
Dividend Per Share	-	0.220	0.200	0.180	0.150
Dividend Growth	-	10.00%	11.11%	20.00%	-
Gross Margin	60.82%	57.82%	58.10%	58.27%	61.88%
Operating Margin	12.00%	11.53%	11.61%	11.61%	12.74%
Profit Margin	12.35%	11.26%	10.38%	10.50%	11.80%
Free Cash Flow Margin	7.65%	4.23%	7.14%	3.98%	3.14%
EBITDA	149.38	142.91	130.16	117.8	99.85
EBITDA Margin	15.34%	14.57%	13.36%	13.27%	14.89%
D&A For EBITDA	32.51	29.79	17.07	14.74	14.45
EBIT	116.87	113.11	113.1	103.05	85.39
EBIT Margin	12.00%	11.53%	11.61%	11.61%	12.74%
Effective Tax Rate	12.43%	13.70%	13.45%	13.27%	14.19%
Revenue as Reported	-	980.83	974.29	887.48	670.31
Advertising Expenses	-	1.09	1.76	3.68	0.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.